Pharm Flashcards
Km
=[S] at 1/2 Vmax; inverse to affinity for substrate
Vmax
Directly proportional to enzyme concentration (V of saturation)
Competitive inhibitor
Same Vmax, lower Km (takes longer to reach vmax); reversible
Noncompetitive inhibitor
Higher Km, lower Vmax
Cooperative kinetics
Sigmoid curve (like hemoglobin)
Most enzymes have a ____ curve
Hyperbolic
On a lineweaver burk plot
High y intercept = lower V max (1/V on Y axis); further right x intercept (closer to zero) –> higher Km, lower affinity
Reversible competitive inhibitors -- Resemble substrate Overcome by increased [S] Bind active site Effect on Vmax Effect on Km Pharmacodynamics
Resemble substrate: yes Overcome by increased [S]: yes Bind active site: yes Effect on Vmax: no change Effect on Km: increased Pharmacodynamics: decreased potency
Irreversible competitive inhibitors -- Resemble substrate Overcome by increased [S] Bind active site Effect on Vmax Effect on Km Pharmacodynamics
Resemble substrate: yes Overcome by increased [S]: no Bind active site: yes Effect on Vmax: decreased Effect on Km: no change Pharmacodynamics: decreased efficacy
Noncompetitive inhibitors -- Resemble substrate Overcome by increased [S] Bind active site Effect on Vmax Effect on Km Pharmacodynamics
Resemble substrate: yes Overcome by increased [S]: no Bind active site: yes Effect on Vmax: decreased Effect on Km: no change Pharmacodynamics: decreased efficacy Compared to uncompetitive -- binds equally well no matter whether substrate is bound
Uncompetitive inhibitor
Only binds to an enzyme bound to substrate
Decreases Vmax, decreases Km (increased sticking in enzyme); parallel on LB plot
Vd=
Amount drug in body/plasma drug conc
Low Vd compartment and type
Intravascular large/charged molecules often bound to plasma proteins
Medium Vd compartment and type
ECF small hydrophilic molecules
High Vd compartment and type
All tissues including fat, small lipophilic molecules, esp if bound to tissue protein
CL=
rate of elimination/plasma drug conc. (volume of plasma cleared of drug per unit of time)
aka Vd*Ke (elimination const)
How many half lives to reach steady state in 1st order kinetics?
4-5
How many half lives to reach 90% of steady state in first order kinetics?
3.3
T1/2 in first order kin=
(0.693*Vd)/CL
Loading dose=
(Cp*Vd)/F
Where Cp is conc. at steady state
F is bioavailability
Maintenance dose=
(CpCLt)/F
Where Cp is conc at steady state
F is bioavailability
t is dosage interval
In renal and liver disease, how do maintenance doses change?
Maintenance goes down
In renal and liver disease, how do loading doses change?
Loading dose doesn’t change (trick q)
Additive drug effect
Effect of A+B=sum of individual effects